Day One Biopharmaceuticals Inc (DAWN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Day One Biopharmaceuticals Inc-Aktie (DAWN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	34.99% 53.72	39.80	33.91	30.76	29.21
Operating Expenses	26.75% 81.18	64.05	68.88	71.83	94.54
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	26.75% 81.18	64.05	68.88	71.83	94.54
Operating Income/Loss	13.22% -27.46	-24.25	-34.97	-41.07	-65.33
Nonoperating Income/Loss	7.09% 4.204	4.525	4.652	5.071	6.092
Income/Loss From Continuing Operations Before Tax	34.99% 53.72	39.80	-30.32	-36.00	29.21
Income Tax Expense/Benefit	-1.976	-	-	-	6.474
Income/Loss From Continuing Operations After Tax	632.19% -211.79	39.80	-30.32	-36.00	-6.474
Net Income/Loss	-107.32	-	-30.32	-36.00	-6.474
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	536.20% -86.04	19.73	30.32	36.00	59.24
Basic Average Shares	99.86% 0.1497	103.38	103.07	102.71	3.0693
Diluted Average Shares	99.86% 0.1497	103.38	103.07	102.71	3.0693
Basic Earnings Per Share	10.53% -0.21	-0.19	-0.29	-0.35	-0.69
Diluted Earnings Per Share	10.53% -0.21	-0.19	-0.29	-0.35	-0.69
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-